3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
9
Non-metastatic Castration-resistant Prostate Cancer
4
Neoplasm Metastasis
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Urogenital Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Non-metastatic Prostate Cancer
1
Metastatic Hormone-sensitive Prostate Cancer
1
Fatigue
1
Depression
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Prostate Carcinoma
1
Interventions
Surveys and Questionnaires
9
Psychiatric Rehabilitation
7
Therapeutics
2
Interviews as Topic
2
Chemotherapy, Adjuvant
2
pegfilgrastim
1
enzalutamide
1
darolutamide
1
apalutamide
1
Vortioxetine
1
Venlafaxine Hydrochloride
1
Transurethral Resection of Prostate
1
Thyroidectomy
1
Tamoxifen
1
Standard of Care
1
Single Person
1
Sertraline
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Physical Examination
1
Palliative Care
1
Observation
1
Models, Nursing
1
Metformin
1
Mental Status and Dementia Tests
1
Granulocyte Colony-Stimulating Factor
1
Genetic Testing
1
Gene Expression Profiling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Depression
×
darolutamide
×
Clear all
NCT07181122
2026-04-28
PRO-MIND
Ankara Etlik City Hospital
Recruiting
102 enrolled